부비강 확장 기기 시장 보고서 : 제품 유형, 시술, 환자 유형, 최종사용자, 지역별(2025-2033년)

The global sinus dilation devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033.

Sinus dilation, also known as balloon sinuplasty, is a minimally invasive procedure that opens blocked sinus passages, allow adequate airflow, and restore natural drainage. It relies on various implantable devices to improve the patency of sinus openings, deliver local medication, and reduce postoperative inflammation. As these devices help in quick recovery, they are gaining traction over conventional sinus devices to treat chronic rhinosinusitis (CRS) refractory worldwide. Besides this, they can be combined with other techniques for patients with significant inflammation in the ethmoid or other sinuses. Nowadays, several manufacturers are introducing devices integrated with microsensors to determine device position during surgeries.

Sinus Dilation Devices Market Trends:

Factors like nasal polyps, nasotracheal tubes, allergic rhinitis, deviated septum, facial bone abnormalities, swollen adenoids, and cleft palate increase the likelihood of developing chronic sinusitis. This, coupled with a significant rise in the prevalence of these factors among the geriatric population, represents one of the key factors bolstering the market growth. In addition to this, the growing number of patients with tumors, diabetes, cystic fibrosis, ciliary dyskinesia, Kartagener syndrome, and human immunodeficiency virus (HIV) infection is contributing to market growth. Moreover, children generally have a higher risk of developing acute bronchitis, including sinusitis. This, in confluence with the increasing concerns among parents about the health of their children, is catalyzing the demand for sinus dilation surgeries and devices around the world. Apart from this, the emerging trend of minimally invasive surgeries (MIS) over conventional open surgeries is influencing the market positively. Furthermore, the improving healthcare infrastructure and rising funding to introduce novel sinus dilation devices are projected to offering lucrative growth opportunities to market players.

Key Market Segmentation:

Breakup by Product:

• Balloon Sinus Dilation Devices
• Sinus Implants
• Handheld Instruments
• Endoscopes
• Others

Breakup by Procedure:

• Standalone
• Hybrid

Breakup by Patient Type:

• Adult
• Pediatric

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetna Inc. (CVS Health Corporation), Dalent Medical, Innaccel Technologies Pvt. Ltd, Intersect ENT Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Meril Life Sciences Pvt. Ltd, Olympus Corporation, Sinusys Corporation, Smith & Nephew plc and Stryker Corporation.

Key Questions Answered in This Report

• 1.What was the size of the global sinus dilation devices market in 2024?
• 2.What is the expected growth rate of the global sinus dilation devices market during 2025-2033?
• 3.What are the key factors driving the global sinus dilation devices market?
• 4.What has been the impact of COVID-19 on the global sinus dilation devices market?
• 5.What is the breakup of the global sinus dilation devices market based on the product?
• 6.What is the breakup of the global sinus dilation devices market based on the procedure?
• 7.What is the breakup of the global sinus dilation devices market based on the patient type?
• 8.What is the breakup of the global sinus dilation devices market based on the end user?
• 9.What are the key regions in the global sinus dilation devices market?
• 10.Who are the key players/companies in the global sinus dilation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Sinus Dilation Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Balloon Sinus Dilation Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Sinus Implants
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Handheld Instruments
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Endoscopes
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 Standalone
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Hybrid
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Patient Type

• 8.1 Adult
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pediatric
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Aetna Inc. (CVS Health Corporation)
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 SWOT Analysis
  • 15.3.2 Dalent Medical
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Innaccel Technologies Pvt. Ltd
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Intersect ENT Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
  • 15.3.5 Johnson & Johnson
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Karl Storz SE & Co. KG
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 SWOT Analysis
  • 15.3.7 Medtronic plc
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Meril Life Sciences Pvt. Ltd
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Olympus Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Sinusys Corporation
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Smith & Nephew plc
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Stryker Corporation
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis